• 1
    Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 1999; 42: 4650.
  • 2
    McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995; 38: 126070.
  • 3
    Odutola J, Ward MM. Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol 2005; 17: 14752.
  • 4
    Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 11307.
  • 5
    Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwett CM. Socioeconomic status and health in women with systemic lupus erythematosus. J Rheumatol 1998; 25: 17209.
  • 6
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 4756.
  • 7
    Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797806.
  • 8
    Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003; 12: 2806.
  • 9
    Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 110718.
  • 10
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 63040.
  • 11
    Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al, and Members of the British Isles Lupus Assessment Group (BILAG). Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988; 69: 92737.
  • 12
    Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Scuito M, et al, and The European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 5417.
  • 13
    Costenbader KH, Karlson EW, Gall V, de Pablo P, Finckh A, Lynch M, et al. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum 2005; 53: 71823.
  • 14
    Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB, et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 2006; 45: 5360.
  • 15
    Yazdany J, Gillis JZ, Panopalis P, Julian L, Katz P, Yelin E. Racial/ethnic differences in the prevalence and treatment of major depressive disorder in a large observational cohort of persons with systemic lupus erythematosus [abstract]. Arthritis Rheum 2006; 54 Suppl 9: S2745.
  • 16
    Katz R, Petri M, Karlson EW, Alarcon GS, Chakravarty E, Goldman J, et al. Performance of the SLAQ in SLE and non-SLE subjects in a longitudinal databank [abstract]. Arthritis Rheum 2007; 56 Suppl 9: S733.
  • 17
    Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 5663.
  • 18
    Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 32: 22033.
  • 19
    Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center; 1993.
  • 20
    Katz PP, Morris A, Yelin EH. Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 7639.
  • 21
    US Bureau of the Census. Current population survey technical documentation. Washington (DC): US Department of Commerce; 1993.
  • 22
    Nunnally J, Berstein IH. Psychometric theory. New York: McGraw-Hill; 1994.
  • 23
    Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997; 50: 23946.
  • 24
    Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. J Clin Epidemiol 2003; 41: 58292.
  • 25
    Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Lawrence Erlbaum; 1988.
  • 26
    Corzillius M, Fortin P, Stucki G. Responsiveness and sensitivity to change of SLE disease activity measures. Lupus 1999; 8: 6559.
  • 27
    Alarcon GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman JM, et al, and the LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006; 65: 116874.
  • 28
    Alarcon GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. II. Features predictive of disease activity early in its course. Arthritis Rheum 1998; 41: 117380.
  • 29
    Andrade RM, Alarcon GS, Fernandez M, Apte M, Vila LM, Reveille JD, for the LUMINA Study Group. Accelerated damage accrual among men with systemic lupus erythematosus. XLIV. Results from a multiethnic US cohort. Arthritis Rheum 2007; 56: 62230.
  • 30
    Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983; 62: 32734.
  • 31
    Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, et al. Do lupus disease activity measures detect clinically important change? J Rheumatol 2000; 27: 14218.
  • 32
    Chang E, Abrahamowicz M, Ferland D, Fortin PR, and the CaNIOS Investigators. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol 2002; 55: 48897.
  • 33
    Wluka AE, Liang MH, Partridge AJ, Fossel AH, Wright EA, Lew RA, et al. Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum 1997; 40: 5761.